Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

被引:14
|
作者
De-la-Cruz-Ku, Gabriel [1 ]
Luyo, Marianne [2 ]
Morante, Zaida [3 ]
Enriquez, Daniel [3 ]
Moller, Mecker G. [4 ]
Chambergo-Michilot, Diego [1 ,5 ]
Flores, Lucero [1 ]
Luque, Renato [1 ,6 ]
Saavedra, Antonella [1 ,6 ]
Eyzaguirre-Sandoval, Miguel E. [1 ,6 ]
Lujan-Peche, Maria G. [1 ,6 ]
Noel, Naysha [1 ]
Calderon, Hafid [1 ,6 ]
Razuri, Cesar [7 ]
Fuentes, Hugo A. [3 ]
Manuel Cotrina, Jose [3 ]
Neciosup, Silvia P. [3 ]
Araujo, Jhajaira [8 ]
Lema, Alexandra [9 ]
Pinto, Joseph [8 ]
Gomez, Henry L. [3 ]
Valcarcel, Bryan [10 ]
机构
[1] Univ Cient Sur UCSUR, Sch Med, Lima, Peru
[2] Univ Peruana Cayetano Heredia, Lima, Peru
[3] Inst Nacl Enfermedades Neoplas, Lima, Peru
[4] Univ Miami, Miller Sch Med, Div Surg Oncol, Jackson Mem Hosp,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[5] Tau RELAPED Grp, Trujillo, Peru
[6] Soc Cient Estudiantes Med Humana SCIEM UCSUR, Lima, Peru
[7] Hosp Nacl Mayo, Lima, Peru
[8] Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru
[9] Univ Cuenca, Hlth Sci Fac, Cuenca, Ecuador
[10] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA
来源
PLOS ONE | 2020年 / 15卷 / 08期
关键词
FAMILY-HISTORY; SURVIVAL; WOMEN; PROGNOSIS; SUBTYPES; IMPACT; ASSOCIATION; RECURRENCE; MASTECTOMY; OUTCOMES;
D O I
10.1371/journal.pone.0237811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. Methods We reviewed the medical records of new cases treated at a single institution in the period 2000-2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. Results Among the 2007 patients included, the median age at diagnosis was 49 years (19-95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05-3.15) and mortality (HR: 2.51, 95% CI: 2.01-3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. Conclusion The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Germline Mutations in Triple-Negative Breast Cancer
    Hahnen, Eric
    Hauke, Jan
    Engel, Christoph
    Neidhardt, Guido
    Rhiem, Kerstin
    Schmutzler, Rita K.
    BREAST CARE, 2017, 12 (01) : 15 - 19
  • [2] Novel prognostic markers for patients with triple-negative breast cancer
    Zhou, Ling
    Li, Ke
    Luo, Yanli
    Tian, Ling
    Wang, Min
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (10) : 2180 - 2187
  • [3] Triple-negative breast cancer in the older population
    Boyle, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 7 - 12
  • [4] Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
    Kim, Jeong Eun
    Ahn, Heui June
    Ahn, Jin-Hee
    Yoon, Dok Hyun
    Kim, Sung-Bae
    Jung, Kyung Hae
    Gong, Gyung-Yub
    Kim, Mi-Jung
    Son, Byung Ho
    Ahn, Sei Hyun
    JOURNAL OF BREAST CANCER, 2012, 15 (02) : 197 - 202
  • [5] Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer
    Luo, Anqi
    Wu, Fang
    Han, Rui
    Huang, Shangke
    Zhang, Yujiao
    Jing, Xin
    Zhao, Xinhan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (05) : 778 - 784
  • [6] Triple-negative breast cancer: An institutional analysis
    Gogia, A.
    Raina, V
    Deo, S. V. S.
    Shukla, N. K.
    Mohanti, B. K.
    INDIAN JOURNAL OF CANCER, 2014, 51 (02) : 163 - 166
  • [7] Understanding the biology of triple-negative breast cancer
    Criscitiello, C.
    Azim, H. A., Jr.
    Schouten, P. C.
    Linn, S. C.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 13 - 18
  • [8] Distant metastasis in triple-negative breast cancer
    Tseng, L. M.
    Hsu, N. C.
    Chen, S. C.
    Lu, Y. S.
    Lin, C. H.
    Chang, D. Y.
    Li, H.
    Lin, Y. C.
    Chang, H. K.
    Chao, T. C.
    Ouyang, F.
    Hou, M. F.
    NEOPLASMA, 2013, 60 (03) : 290 - 294
  • [9] Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer
    Algan, Ozer
    Zhao, Yan D.
    Herman, Terence
    CLINICAL BREAST CANCER, 2016, 16 (04) : E99 - E106
  • [10] Outcomes for Patients with Non-metastatic Triple-negative Breast Cancer in New Zealand
    James, M.
    Dixit, A.
    Robinson, B.
    Frampton, C.
    Davey, V
    CLINICAL ONCOLOGY, 2019, 31 (01) : 17 - 24